The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
EpCAM (CD326) finding its role in cancer
Open accessAbstract
Although epithelial cell adhesion/activating molecule (EpCAM/CD326) is one of the first tumour-associated antigens identified, it has never received the same level of attention as other target proteins for therapy of cancer. It is also striking that ever since its discovery in the late 1970s the actual contribution of EpCAM to carcinogenesis remained unexplored until very recently. With a First International Symposium on EpCAM Biology and Clinical Application this is now changing. Key topics discussed at the meeting were the frequency and level of EpCAM expression on various cancers and its prognostic potential, the role of EpCAM as an oncogenic signalling molecule for cancer cells, recent progress on EpCAM-directed immunotherapeutic approaches in clinical development and the interaction of EpCAM with other proteins, which may provide a basis for a therapeutic window and repression of its growth-promoting signalling in carcinoma. Future research on EpCAM may benefit from a unified nomenclature and more frequent exchange among those who have been working on this cancer target during the past 30 years and will do so in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., Schlimok, G., Diel, I. J., Gerber, B., Gebauer, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050434 · Cited by 1,379
Frequent EpCam protein expression in human carcinomas
Went, P. T. H., Lugli, A., Meier, S., Bundi, M., Mirlacher, M., Sauter, G., & Dirnhofer, S. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.08.026 · Cited by 819
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.
Herlyn, M., Steplewski, Z., Herlyn, D., & Koprowski, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1438 · Cited by 656
Riethmüller, G., Gruber, R., Schneider-Gädicke, E., Schlimok, G., Witte, J., Raab, R., Pichlmayr, R., Pichlmaier, H., Schmiegel, W., Buggisch, P., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92398-1 · Cited by 633
EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy
Osta, W. A., Chen, Y., Mikhitarian, K., Mitas, M., Salem, M., Hannun, Y. A., Cole, D. J., & Gillanders, W. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0754 · Cited by 563
Riethmüller, G., Holz, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Funke, I., Pichlmaier, H., Hirche, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1788 · Cited by 517
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N. H., & Riethmüller, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09838-0 · Cited by 479
Müller, V., Stahmann, N., Riethdorf, S., Rau, T., Zabel, T., Goetz, A., Jänicke, F., & Pantel, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2469 · Cited by 403
Went, P., Vasei, M., Bubendorf, L., Terracciano, L., Tornillo, L., Riede, U., Kononen, J., Simon, R., Sauter, G., & Baeuerle, P. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602924 · Cited by 387
Self-citationThe carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
Münz, M., Kieu, C., Mack, B., Schmitt, B., Zeidler, R., & Gires, O. (2004) · Oncogene · doi:10.1038/sj.onc.1207610 · Cited by 368
Self-citationRao, C., Chianese, D., Doyle, G., Miller, M., Russell, T., Sanders, R., & Terstappen, L. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.1.49 · Cited by 327
Combined transcriptome and genome analysis of single micrometastatic cells
Klein, C. A., Seidl, S., Petat-Dutter, K., Offner, S., Geigl, J. B., Schmidt-Kittler, O., Wendler, N., Passlick, B., Huber, R. M., Schlimok, G., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-387 · Cited by 303
Self-citationBrischwein, K., Schlereth, B., Guller, B., Steiger, C., Wolf, A., Lutterbuese, R., Offner, S., Locher, M., Urbig, T., Raum, T., et al. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.034 · Cited by 256
Self-citationHigh Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer
Spizzo, G., Gastl, G., Obrist, P., Went, P., Dirnhofer, S., Bischoff, S., Mirlacher, M., Sauter, G., Simon, R., Stopatschinskaya, S., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000036787.59816.01 · Cited by 254
Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells
Nomura, T., & Katunuma, N. (2005) · The Journal of Medical Investigation · doi:10.2152/jmi.52.1 · Cited by 244
Göitlinger, H. G., Funke, I., Johnson, J. P., Gokel, J. M., & Riethmüller, G. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380109 · Cited by 233
Punt, C. J., Nagy, A., Douillard, J.-Y., Figer, A., Skovsgaard, T., Monson, J., Barone, C., Fountzilas, G., Riess, H., Moylan, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09836-7 · Cited by 213
Williams, L. N. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92992-4 · Cited by 213
Spizzo, G., Went, P., Dirnhofer, S., Obrist, P., Moch, H., Baeuerle, P. A., Mueller-Holzner, E., Marth, C., Gastl, G., & Zeimet, A. G. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.035 · Cited by 201
Self-citationJanni, W., Rack, B., Schindlbeck, C., Strobl, B., Rjosk, D., Braun, S., Sommer, H., Pantel, K., Gerber, B., & Friese, K. (2005) · Cancer · doi:10.1002/cncr.20834 · Cited by 169
Varga, M., Obrist, P., Schneeberger, S., Mühlmann, G., Felgel-Farnholz, C., Fong, D., Zitt, M., Brunhuber, T., Schäfer, G., Gastl, G. A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0528 · Cited by 145
Evidence for a Role of the Epithelial Glycoprotein 40 (Ep-CAM) in Epithelial Cell-Cell Adhesion
Litvinov, S. V., Bakker, H. A. M., Gourevitch, M. M., Velders, M. P., & Warnaar, S. O. (1994) · Cell Communication & Adhesion · doi:10.3109/15419069409004452 · Cited by 137
Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733.
Linnenbach, A. J., Wojcierowski, J., Wu, S., Pyrc, J. J., Ross, A. H., Dietzschold, B., Speicher, D. W., & Koprowski, H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.27 · Cited by 136
Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer.
Miyake, M., NAKANO, K., Itoi, S. I., Koh, T., & Taki, T. (1996) · PubMed · Cited by 122
Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance
Fong, D., Steurer, M., Obrist, P., Barbieri, V., Margreiter, R., Amberger, A., Laimer, K., Gastl, G. A., Tzankov, A., & Spizzo, G. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.037333 · Cited by 116
Si, Z., & Hersey, P. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540107 · Cited by 104
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment
Naundorf, S., Preithner, S., Mayer, P., Lippold, S., Wolf, A., Hanakam, F., Fichtner, I., Kufer, P., Raum, T., Riethmüller, G., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10443 · Cited by 100
Self-citationStoecklein, N. H., Siegmund, A., Scheunemann, P., Luebke, A. M., Erbersdobler, A., Verde, P. E., Eisenberger, C. F., Peiper, M., Rehders, A., Esch, J. S. A., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-165 · Cited by 99
Pauli, C., Münz, M., Kieu, C., Mack, B., Breinl, P., Wollenberg, B., Lang, S., Zeidler, R., & Gires, O. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00003-x · Cited by 95
Self-citationChong, J. M., & Speicher, D. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008839200 · Cited by 79
Diversity and Evolution of the Thyroglobulin Type-1 Domain Superfamily
Novinec, M., Kordiš, D., Türk, V., & Lenar≷cic̆, B. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msj082 · Cited by 77
Hartung, G., Hofheinz, R. D., Dencausse, Y., Sturm, J., Kopp‐Schneider, A., Dietrich, G., Fackler-Schwalbe, I., Bornbusch, D., Gonnermann, M., Wojatschek, C., et al. (2005) · Oncology Research and Treatment · doi:10.1159/000084595 · Cited by 71
Pantel, K., & Wölfle, U. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.07.002 · Cited by 57
Wölfle, U., Breit, E., Zafrakas, K., Otte, M., Schubert, F., Müller, V., Izbicki, J. R., Löning, T., & Pantel, K. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.03.006 · Cited by 49
Spizzo, G., Gastl, G. A., Obrist, P., Fong, D., Haun, M., Grünewald, K., Parson, W., Eichmann, C., Millinger, S., Fiegl, H., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.03.002 · Cited by 38
Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models
Lindhofer, H., Menzel, H., Günther, W., Hültner, L., & Thierfelder, S. (1996) · Blood · doi:10.1182/blood.v88.12.4651.bloodjournal88124651 · Cited by 26
Cited by
Nuclear signalling by tumour-associated antigen EpCAM
Maetzel, D., Denzel, S., Mack, B., Canis, M., Went, P., Benk, M., Kieu, C., Papior, P., Baeuerle, P. A., Munz, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1824 · Cited by 719
Self-citationEpithelial Cell Adhesion Molecule
Trzpis, M., McLaughlin, P. M. J., de Leij, L. M. F. H., & Harmsen, M. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070152 · Cited by 578
Song, Y., Zhu, Z., An, Y., Zhang, W., Zhang, H., Liu, D., Yu, C., Duan, W., & Yang, C. J. (2013) · Analytical Chemistry · doi:10.1021/ac400366b · Cited by 525
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Munz, M., Baeuerle, P. A., & Gires, O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0654 · Cited by 515
Self-citationModern isolation and separation techniques for extracellular vesicles
Liangsupree, T., Multia, E., & Riekkola, M.-L. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461773 · Cited by 512
Metadata
- Authors
- Baeuerle, P. A., & Gires, O.
- Venue
- British Journal of Cancer
- Published
- 2007-01-09
- Volume
- 96
- Issue
- 3
- Pages
- 417-423
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1988835634
- Cited by
- 527
- References
- 37
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.